- 2024-10-17 19:30V-ATPase-IN-1
- 2024-10-17 19:29Boc-PIP-Me-CH2-2,7-diazaspiro[3.5]nonane
- 2024-10-17 19:29EGR-1-IN-2
- 2024-10-17 19:29Anti-osteoporosis agent-11
- 2024-10-17 19:29HCV-796 analog
- 2024-10-17 19:29Anti-MRSA agent 17
- 2024-10-17 19:29DA-143
- 2024-10-17 19:29Tyrphostin 47
- 2024-10-17 19:29Delequamine hydrochloride
- 2024-10-17 19:29SGD-9501-TFA
- 2024-10-17 19:29ATG12-IN-1
- 2024-10-17 19:29KIF18A-IN-13
- 2024-10-17 19:29Thalidomide-O-amido-C7-NH2
- 2024-10-17 19:29RIPK1-IN-26
- 2024-10-17 19:286′‐O‐Galloylsalidroside
- 2024-10-17 19:28Avotaciclib sulfate
- 2024-10-17 19:28(R)-Crinecerfont
- 2024-10-17 19:28ZD-7114
- 2024-10-17 19:28Salmefamol
- 2024-10-17 19:28PROTAC 20S proteasome subunit β5 degrader 2
